{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T10:49:29Z","timestamp":1788778169352,"version":"build-2803163510"},"reference-count":42,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2023,1,17]],"date-time":"2023-01-17T00:00:00Z","timestamp":1673913600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003173","name":"Crafoord foundation","doi-asserted-by":"crossref","award":["20220572"],"award-info":[{"award-number":["20220572"]}],"id":[{"id":"10.13039\/501100003173","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100002794","name":"Swedish Cancer Society","doi-asserted-by":"publisher","award":["CAN 2017\/1019"],"award-info":[{"award-number":["CAN 2017\/1019"]}],"id":[{"id":"10.13039\/501100002794","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004543","name":"China Scholarship Council","doi-asserted-by":"publisher","award":["202008110188"],"award-info":[{"award-number":["202008110188"]}],"id":[{"id":"10.13039\/501100004543","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,4,11]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Studies of obesity with or without metabolic aberrations, commonly termed metabolically unhealthy or healthy obesity, in relation to cancer risk are scarce.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We investigated body mass index (normal weight, overweight, obesity) jointly and in interaction with metabolic health status in relation to obesity-related cancer risk (n\u2009=\u200923\u200a630) among 797\u200a193 European individuals. A metabolic score comprising mid-blood pressure, plasma glucose, and triglycerides was used to define metabolically healthy and unhealthy status. Hazard ratios (HRs) and multiplicative interactions were assessed using Cox regression, and additive interactions were assessed using the relative excess risk for interaction. All statistical tests were 2-sided.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Metabolically unhealthy obesity, with a baseline prevalence of 7%, was, compared with metabolically healthy normal weight, associated with an increased relative risk of any obesity-related cancer and of colon, rectal, pancreas, endometrial, liver, gallbladder, and renal cell cancer (P\u2009&amp;lt;\u2009.05), with the highest risk estimates for endometrial, liver, and renal cell cancer (HR = 2.55-3.00). Metabolically healthy obesity showed a higher relative risk for any obesity-related cancer and colon (in men), endometrial, renal cell, liver, and gallbladder cancer, though the risk relationships were weaker. There were no multiplicative interactions, but there were additive, positive interactions between body mass index and metabolic health status on obesity-related and rectal cancer among men and on endometrial cancer (P\u2009&amp;lt;\u2009.05).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>This study highlights that the type of metabolic obesity phenotype is important when assessing obesity-related cancer risk. In general, metabolic aberrations further increased the obesity-induced cancer risk, suggesting that obesity and metabolic aberrations are useful targets for prevention.<\/jats:p><\/jats:sec>","DOI":"10.1093\/jnci\/djad008","type":"journal-article","created":{"date-parts":[[2023,1,17]],"date-time":"2023-01-17T05:06:13Z","timestamp":1673931973000},"page":"456-467","source":"Crossref","is-referenced-by-count":51,"title":["Metabolically (un)healthy obesity and risk of obesity-related cancers: a pooled study"],"prefix":"10.1093","volume":"115","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4134-6935","authenticated-orcid":false,"given":"Ming","family":"Sun","sequence":"first","affiliation":[{"name":"Department of Translational Medicine, Lund University , Malm\u00f6, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josef","family":"Fritz","sequence":"additional","affiliation":[{"name":"Department of Translational Medicine, Lund University , Malm\u00f6, Sweden"},{"name":"Institute of Medical Statistics and Informatics, Medical University of Innsbruck , Innsbruck, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6808-4405","authenticated-orcid":false,"given":"Christel","family":"H\u00e4ggstr\u00f6m","sequence":"additional","affiliation":[{"name":"Department of Surgical Sciences, Uppsala University , Uppsala, Sweden"},{"name":"Northern Register Centre, Department of Public Health and Clinical Medicine, Ume\u00e5 University , Ume\u00e5, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9096-5257","authenticated-orcid":false,"given":"Tone","family":"Bj\u00f8rge","sequence":"additional","affiliation":[{"name":"Department of Global Public Health and Primary Care, University of Bergen , Bergen, Norway"},{"name":"Section for Cervical Cancer Screening, Cancer Registry of Norway , Oslo, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele","family":"Nagel","sequence":"additional","affiliation":[{"name":"Institute of Epidemiology and Medical Biometry, Ulm University , Ulm, Germany"},{"name":"Agency for Preventive and Social Medicine , Bregenz (aks), Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonas","family":"Manjer","sequence":"additional","affiliation":[{"name":"Department of Surgery, Sk\u00e5ne University Hospital, Lund University , Malm\u00f6, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5620-9207","authenticated-orcid":false,"given":"Anders","family":"Engeland","sequence":"additional","affiliation":[{"name":"Department of Global Public Health and Primary Care, University of Bergen , Bergen, Norway"},{"name":"Department of Chronic Diseases, Norwegian Institute of Public Health , Bergen, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuel","family":"Zitt","sequence":"additional","affiliation":[{"name":"Agency for Preventive and Social Medicine , Bregenz (aks), Austria"},{"name":"Department of Internal Medicine III (Nephrology and Dialysis), Academic Teaching Hospital Feldkirch , Feldkirch, Austria"},{"name":"Vorarlberg Institute for Vascular Investigation and Treatment, Academic Teaching Hospital Feldkirch , Feldkirch, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9692-101X","authenticated-orcid":false,"given":"Bethany","family":"van Guelpen","sequence":"additional","affiliation":[{"name":"Department of Radiation Sciences, Oncology, Ume\u00e5 University , Ume\u00e5, Sweden"},{"name":"Wallenberg Centre for Molecular Medicine, Ume\u00e5 University , Ume\u00e5, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8306-0687","authenticated-orcid":false,"given":"P\u00e4r","family":"Stattin","sequence":"additional","affiliation":[{"name":"Department of Surgical Sciences, Uppsala University , Uppsala, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5911-1002","authenticated-orcid":false,"given":"Hanno","family":"Ulmer","sequence":"additional","affiliation":[{"name":"Institute of Medical Statistics and Informatics, Medical University of Innsbruck , Innsbruck, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0904-0557","authenticated-orcid":false,"given":"Tanja","family":"Stocks","sequence":"additional","affiliation":[{"name":"Department of Translational Medicine, Lund University , Malm\u00f6, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,1,17]]},"reference":[{"key":"2023041108174085800_","doi-asserted-by":"crossref","first-page":"j477","DOI":"10.1136\/bmj.j477","article-title":"Adiposity and cancer at major anatomical sites: umbrella review of the literature","volume":"356","author":"Kyrgiou","year":"2017","journal-title":"BMJ"},{"issue":"8","key":"2023041108174085800_","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1056\/NEJMsr1606602","article-title":"Body fatness and cancer\u2013viewpoint of the IARC working group","volume":"375","author":"Lauby-Secretan","year":"2016","journal-title":"New Engl J Med"},{"key":"2023041108174085800_","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.ebiom.2018.02.022","article-title":"Obesity and cancer: existing and new hypotheses for a causal connection","volume":"30","author":"Stone","year":"2018","journal-title":"EBioMedicine"},{"key":"2023041108174085800_","doi-asserted-by":"crossref","first-page":"789174","DOI":"10.1155\/2012\/789174","article-title":"Insulin resistance and cancer risk: an overview of the pathogenetic mechanisms","volume":"2012","author":"Arcidiacono","year":"2012","journal-title":"Exp Diabetes Res"},{"issue":"11","key":"2023041108174085800_","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.2337\/dc12-0336","article-title":"Metabolic syndrome and risk of cancer: a systematic review and meta-analysis","volume":"35","author":"Esposito","year":"2012","journal-title":"Diabetes Care"},{"issue":"4","key":"2023041108174085800_","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1093\/ije\/dyv001","article-title":"Metabolic risk score and cancer risk: pooled analysis of seven cohorts","volume":"44","author":"Stocks","year":"2015","journal-title":"Int J Epidemiol"},{"issue":"12","key":"2023041108174085800_","doi-asserted-by":"crossref","first-page":"3384","DOI":"10.1002\/ijc.33172","article-title":"Metabolic syndrome and risk of pancreatic cancer: a population-based prospective cohort study","volume":"147","author":"Xia","year":"2020","journal-title":"Int J Cancer"},{"issue":"2","key":"2023041108174085800_","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1053\/j.gastro.2021.09.070","article-title":"Changes in metabolic syndrome status are associated with altered risk of pancreatic cancer: a nationwide cohort study","volume":"162","author":"Park","year":"2022","journal-title":"Gastroenterology"},{"issue":"9","key":"2023041108174085800_","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1158\/1055-9965.EPI-10-0234","article-title":"Metabolic factors and the risk of pancreatic cancer: a prospective analysis of almost 580,000 men and women in the Metabolic Syndrome and Cancer Project","volume":"19","author":"Johansen","year":"2010","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"12","key":"2023041108174085800_","doi-asserted-by":"crossref","first-page":"2687","DOI":"10.1093\/annonc\/mdr025","article-title":"Metabolic syndrome and the risk of breast cancer in postmenopausal women","volume":"22","author":"Rosato","year":"2011","journal-title":"Ann Oncol"},{"issue":"2","key":"2023041108174085800_","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1002\/hep.24397","article-title":"Metabolic syndrome increases the risk of primary liver cancer in the United States: a study in the SEER-Medicare database","volume":"54","author":"Welzel","year":"2011","journal-title":"Hepatology"},{"issue":"1","key":"2023041108174085800_","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/ijc.26338","article-title":"Metabolic risk factors and primary liver cancer in a prospective study of 578,700 adults","volume":"131","author":"Borena","year":"2012","journal-title":"Int J Cancer"},{"issue":"10","key":"2023041108174085800_","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1007\/s00384-021-03974-y","article-title":"Metabolic syndrome and the risk of colorectal cancer: a systematic review and meta-analysis","volume":"36","author":"Shen","year":"2021","journal-title":"Int J Colorectal Dis"},{"issue":"11","key":"2023041108174085800_","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.1002\/cncr.25772","article-title":"Metabolic factors and the risk of colorectal cancer in 580,000 men and women in the metabolic syndrome and cancer project (Me-Can)","volume":"117","author":"Stocks","year":"2011","journal-title":"Cancer"},{"issue":"4","key":"2023041108174085800_","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1093\/annonc\/mdq464","article-title":"Metabolic syndrome and endometrial cancer risk","volume":"22","author":"Rosato","year":"2011","journal-title":"Ann Oncol"},{"issue":"8","key":"2023041108174085800_","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1093\/aje\/kwq006","article-title":"Metabolic syndrome and endometrial carcinoma","volume":"171","author":"Bjorge","year":"2010","journal-title":"Am J Epidemiol"},{"issue":"2","key":"2023041108174085800_","doi-asserted-by":"crossref","first-page":"e57475","DOI":"10.1371\/journal.pone.0057475","article-title":"Metabolic factors associated with risk of renal cell carcinoma","volume":"8","author":"Haggstrom","year":"2013","journal-title":"PLoS One"},{"issue":"9","key":"2023041108174085800_","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1007\/s00125-021-05484-6","article-title":"Are people with metabolically healthy obesity really healthy? A prospective cohort study of 381,363 UK Biobank participants","volume":"64","author":"Zhou","year":"2021","journal-title":"Diabetologia"},{"issue":"2","key":"2023041108174085800_","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1161\/CIRCULATIONAHA.109.887521","article-title":"Impact of body mass index and the metabolic syndrome on the risk of cardiovascular disease and death in middle-aged men","volume":"121","author":"Arnlov","year":"2010","journal-title":"Circulation"},{"issue":"9","key":"2023041108174085800_","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1177\/2047487315623884","article-title":"Metabolically healthy obesity and cardiovascular events: a systematic review and meta-analysis","volume":"23","author":"Eckel","year":"2016","journal-title":"Eur J Prev Cardiol"},{"issue":"10","key":"2023041108174085800_","doi-asserted-by":"crossref","DOI":"10.1111\/obr.13049","article-title":"The association between metabolically healthy obesity and risk of cancer: a systematic review and meta-analysis of prospective cohort studies","volume":"21","author":"Lin","year":"2020","journal-title":"Obesity Reviews"},{"issue":"8","key":"2023041108174085800_","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1038\/s41416-020-1012-6","article-title":"Association of obesity status and metabolic syndrome with site-specific cancers: a population-based cohort study","volume":"123","author":"Cao","year":"2020","journal-title":"Br J Cancer"},{"issue":"1","key":"2023041108174085800_","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1515\/em-2013-0005","article-title":"A tutorial on interaction","volume":"3","author":"VanderWeele","year":"2014","journal-title":"Epidemiol Methods"},{"issue":"3","key":"2023041108174085800_","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1093\/ije\/dyp186","article-title":"Cohort profile: the metabolic syndrome and cancer project (Me-Can)","volume":"39","author":"Stocks","year":"2010","journal-title":"Int J Epidemiol"},{"issue":"1","key":"2023041108174085800_","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1002\/ijc.32240","article-title":"Linear age-course effects on the associations between body mass index, triglycerides, and female breast and male liver cancer risk: an internal replication study of 800,000 individuals","volume":"146","author":"Haggstrom","year":"2020","journal-title":"Int J Cancer"},{"key":"2023041108174085800_","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/s12872-016-0257-8","article-title":"Blood pressure changes during 22-year of follow-up in large general population - the HUNT Study, Norway","volume":"16","author":"Holmen","year":"2016","journal-title":"BMC Cardiovasc Disord"},{"key":"2023041108174085800_","author":"Statistics Norway","year":"2022"},{"key":"2023041108174085800_","doi-asserted-by":"crossref","first-page":"b2393","DOI":"10.1136\/bmj.b2393","article-title":"Multiple imputation for missing data in epidemiological and clinical research: potential and pitfalls","volume":"338","author":"Sterne","year":"2009","journal-title":"BMJ"},{"issue":"9349","key":"2023041108174085800_","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1016\/S0140-6736(02)11911-8","article-title":"Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies","volume":"360","author":"Lewington","year":"2002","journal-title":"Lancet"},{"issue":"1","key":"2023041108174085800_","doi-asserted-by":"crossref","first-page":"e54242","DOI":"10.1371\/journal.pone.0054242","article-title":"Total serum cholesterol and cancer incidence in the Metabolic syndrome and Cancer Project (Me-Can)","volume":"8","author":"Strohmaier","year":"2013","journal-title":"PLoS One"},{"issue":"10","key":"2023041108174085800_","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1111\/obr.12198","article-title":"The prevalence of metabolically healthy obesity: a systematic review and critical evaluation of the definitions used","volume":"15","author":"Rey-Lopez","year":"2014","journal-title":"Obes Rev"},{"issue":"2","key":"2023041108174085800_","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1002\/oby.22377","article-title":"Metabolically healthy obesity and risk for atrial fibrillation: the HUNT study","volume":"27","author":"Feng","year":"2019","journal-title":"Obesity (Silver Spring)"},{"issue":"6","key":"2023041108174085800_","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.orcp.2019.10.002","article-title":"Metabolically healthy obesity (MHO) in the Malmo diet cancer study\u2013epidemiology and prospective risks","volume":"13","author":"Korduner","year":"2019","journal-title":"Obes Res Clin Pract"},{"issue":"6","key":"2023041108174085800_","doi-asserted-by":"crossref","first-page":"067013","DOI":"10.1289\/EHP334","article-title":"Statistical approaches for estimating sex-specific effects in endocrine disruptors research","volume":"125","author":"Buckley","year":"2017","journal-title":"Environ Health Perspect"},{"issue":"2","key":"2023041108174085800_","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1177\/1536867X0400400201","article-title":"Cumulative incidence estimation in the presence of competing risks","volume":"4","author":"Coviello","year":"2004","journal-title":"Stata J"},{"issue":"5","key":"2023041108174085800_","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1097\/00001648-199209000-00012","article-title":"Confidence interval estimation of interaction","volume":"3","author":"Hosmer","year":"1992","journal-title":"Epidemiology"},{"issue":"8","key":"2023041108174085800_","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.2337\/dc12-1654","article-title":"Metabolically healthy obesity and risk of mortality: does the definition of metabolic health matter?","volume":"36","author":"Hinnouho","year":"2013","journal-title":"Diabetes Care"},{"issue":"3","key":"2023041108174085800_","doi-asserted-by":"crossref","DOI":"10.1210\/endrev\/bnaa004","article-title":"Metabolically healthy obesity","volume":"41","author":"Bluher","year":"2020","journal-title":"Endocr Rev"},{"issue":"2","key":"2023041108174085800_","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s13679-020-00375-0","article-title":"Metabolically healthy obesity: criteria, epidemiology, controversies, and consequences","volume":"9","author":"Tsatsoulis","year":"2020","journal-title":"Curr Obes Rep"},{"issue":"7","key":"2023041108174085800_","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1158\/1055-9965.EPI-10-0230","article-title":"Metabolic syndrome and breast cancer in the Me-Can (Metabolic Syndrome and Cancer) Project","volume":"19","author":"Bjorge","year":"2010","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"1","key":"2023041108174085800_","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1080\/02841860802247664","article-title":"The completeness of the Swedish Cancer Register: a sample survey for year 1998","volume":"48","author":"Barlow","year":"2009","journal-title":"Acta Oncol"},{"issue":"7","key":"2023041108174085800_","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1016\/j.ejca.2008.10.037","article-title":"Data quality at the Cancer Registry of Norway: an overview of comparability, completeness, validity and timeliness","volume":"45","author":"Larsen","year":"2009","journal-title":"Eur J Cancer"}],"container-title":["JNCI: Journal of the National Cancer Institute"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jnci\/advance-article-pdf\/doi\/10.1093\/jnci\/djad008\/49101451\/djad008.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jnci\/article-pdf\/115\/4\/456\/49808461\/djad008.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jnci\/article-pdf\/115\/4\/456\/49808461\/djad008.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,4]],"date-time":"2023-12-04T13:46:52Z","timestamp":1701697612000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jnci\/article\/115\/4\/456\/6986978"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,17]]},"references-count":42,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2023,1,17]]},"published-print":{"date-parts":[[2023,4,11]]}},"URL":"https:\/\/doi.org\/10.1093\/jnci\/djad008","relation":{},"ISSN":["0027-8874","1460-2105"],"issn-type":[{"value":"0027-8874","type":"print"},{"value":"1460-2105","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,4,1]]},"published":{"date-parts":[[2023,1,17]]}}}